VT ablation based on CT imaging substrate visualization: results from a large cohort of ischemic and non-ischemic cardiomyopathy patients

被引:7
|
作者
Englert, F. [1 ]
Bahlke, F. [1 ]
Erhard, N. [1 ]
Krafft, H. [1 ]
Popa, M. -a. [1 ]
Risse, E. [1 ]
Lennerz, C. [1 ]
Lengauer, S. [1 ]
Telishevska, M. [1 ]
Reents, T. [1 ]
Kottmaier, M. [1 ]
Kolb, C. [1 ]
Hessling, G. [1 ]
Deisenhofer, I. [1 ]
Bourier, F. [1 ]
机构
[1] Tech Univ Munich TUM, German Heart Ctr Munich, Dept Electrophysiol, Lazarettstr 36, D-80636 Munich, Germany
关键词
VT ablation; inHEART; Cardiomyopathy; Wall thinning; Late enhancement; VENTRICULAR-TACHYCARDIA; SCAR;
D O I
10.1007/s00392-023-02321-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction The eradication of ventricular tachycardia (VT) isthmus sites constitutes the minimal procedural endpoint for VT ablation procedures. Contemporary high-resolution computed tomography (CT) imaging, in combination with computer-assisted analysis and segmentation of CT data, facilitates targeted elimination of VT isthmi. In this context, inHEART offers digitally rendered three-dimensional (3D) cardiac models which allow preoperative planning for VT ablations in ischemic and non-ischemic cardiomyopathies. To date, almost no data have been collected to compare the outcomes of VT ablations utilizing inHEART with those of traditional ablation approaches.Methods The presented data are derived from a retrospective analysis of n = 108 patients, with one cohort undergoing VT ablation aided by late-enhancement CT and subsequent analysis and segmentation by inHEART, while the other cohort received ablation through conventional methods like substrate mapping and activation mapping. The ablations were executed utilizing a 3D mapping system (Carto3), with the mapping generated via the CARTO (R) PENTARAY (TM) NAV catheter and subsequently merged with the inHEART model, if available.Results Results showed more successful outcome of ablations for the inHEART group with lower VT recurrence (27% vs. 42%, p < 0.06). Subsequent analyses revealed that patients with ischemic cardiomyopathies appeared to derive a significant benefit from inHEART-assisted VT ablation procedures, with a higher rate of successful ablation (p = 0.05).Conclusion Our findings indicate that inHEART-guided ablation is associated with reduced VT recurrence compared to conventional procedures. This suggests that employing advanced imaging and computational modeling in VT ablation may be valuable for VT recurrences.
引用
收藏
页码:1478 / 1484
页数:7
相关论文
共 50 条
  • [1] Ventricular Tachycardia Ablation in Non-ischemic Cardiomyopathy
    Bhaskaran, Ashwin
    De Silva, Kasun
    Rao, Karan
    Campbell, Timothy
    Trivic, Ivana
    Bennett, Richard G.
    Kizana, Eddy
    Kumar, Saurabh
    KOREAN CIRCULATION JOURNAL, 2020, 50 (03) : 203 - 219
  • [2] Differences in the Outcomes of Catheter Ablation for Ventricular Tachycardia in Patients With Ischemic versus Non-Ischemic Cardiomyopathy
    Woelber, Tiffany
    Dhawan, Rahul
    Dai, Qiying
    Desimone, Christopher V.
    Killu, Ammar M.
    Siontis, Konstantinos
    Deshmukh, Abhishek
    Kowlgi, Gurukripa N.
    CIRCULATION, 2023, 148
  • [3] Influence of Ischemic and Non-Ischemic Cardiomyopathy on Catheter Ablation for Atrial Fibrillation
    Arora, Shilpkumar
    Dave, Mihir
    Tripathy, Byomesh
    Lahewala, Sopan
    Patel, Nilay
    Patel, Nileshkumar
    Kumar, Varun
    Varma, Yash
    Malhotra, Shikha
    Gidwani, Umesh
    Badheka, Apurva
    Deshmukh, Abhishek
    Viles-Gonzalez, Juan F.
    CIRCULATION, 2018, 138
  • [4] Is There a Difference in Benefits from Cardiac Resynchronization Therapy in Ischemic and Non-Ischemic Cardiomyopathy Patients?
    Makki, Nader
    Swaminathan, Paari Dominic
    Olshansky, Brian
    CIRCULATION, 2012, 126 (21)
  • [5] Outcomes of ventricular tachycardia ablation in patients with ischemic and non-ischemic cardiomyopathy: A propensity-score matched analysis
    Gomes, Daniel A.
    Paiva, Mariana Sousa
    Matos, Daniel
    Bello, Ana Rita
    Rodrigues, Gustavo
    Carmo, Joao
    Ferreira, Jorge
    Costa, Francisco Moscoso
    Santos, Pedro Galvao
    Carmo, Pedro
    Cavaco, Diogo
    Morgado, Francisco Bello
    Adragao, Pedro
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2024, 43 (06) : 341 - 349
  • [6] Implantable cardioverter defibrillator therapy in patients with ischemic or non-ischemic cardiomyopathy and nonsustained ventricular tachycardia
    Evonich, RF
    Maheshwari, A
    Gardiner, JC
    Khasnis, A
    Kantipudi, S
    Ip, JH
    Grimes, D
    Hayter, G
    Thakur, RK
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2004, 11 (01) : 59 - 65
  • [7] Implantable Cardioverter Defibrillator Therapy in Patients with Ischemic or Non-Ischemic Cardiomyopathy and Nonsustained Ventricular Tachycardia
    Rudolph F. Evonich
    Alok Maheshwari
    Joseph C. Gardiner
    Atul Khasnis
    Sricharan Kantipudi
    John H. Ip
    Denise Grimes
    Gregory Hayter
    Ranjan K. Thakur
    Journal of Interventional Cardiac Electrophysiology, 2004, 11 : 59 - 65
  • [8] Functional Molecular Imaging Characteristics of Ischemic and Non-Ischemic Scar Substrate and successful VT Ablation Sites using 18F-Fluorodeoxyglucose (FDG) Positron Emission Tomography
    Abdulghani, Mohammed S.
    Asoglu, Ramazan
    Smith, Mark
    Chen, Wengen
    Vunnam, Rama
    Klein, Tommas
    Saliaris, Anastasios
    See, Vincent
    Shorofsky, Stephen
    Dilsizian, Vasken
    Dickfeld, Timm
    CIRCULATION, 2014, 130
  • [9] CT-imaging versus high-density mapping in ischemic cardiomyopathy VT ablation: In whom do we trust?
    Fink, Thomas
    Sciacca, Vanessa
    Sommer, Philipp
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2022, 33 (10) : 2181 - 2182
  • [10] Delayed-enhanced magnetic resonance imaging for identifying the ventricular arrhythmia substrate in non-ischemic cardiomyopathy
    Benoit Desjardins
    Fred Morady
    Frank Bogun
    Journal of Cardiovascular Magnetic Resonance, 11 (Suppl 1)